Browse

Oral Presentation Abstracts

AHNS-081

ASSESSING THE VALUE EQUATION FOR OLDER PATIENTS RECEIVING RADIOTHERAPY WITH OR WITHOUT CISPLATIN OR CETUXIMAB FOR LOCOREGIONALLY-ADVANCED HEAD AND NECK CANCER

Value / Quality

Anirudh Saraswathula, BS1, Michelle M Chen, MD, MHS2, Alexander D Colevas, MD3, Vasu Divi, MD2

1Stanford University School of Medicine, 2Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, 3Division of Oncology, Department of Medicine, Stanford University School of Medicine


AHNS-082

SOCIOECONOMIC AND DEMOGRAPHIC VARIATION IN INSURANCE COVERAGE AMONG HEAD AND NECK CANCER PATIENTS AFTER THE AFFORDABLE CARE ACT

Value / Quality

Neelima Panth, MPH1, Justin Barnes, MS2, Rosh K Sethi, MD, MPH3, Eric Adjei Boakye, PhD4, Mark A Varvares, MD3, Nosayaba Osazuwa Peters, PhD, BDS, MPH, CHES2

1Duke University School of Medicine, 2St. Louis University School of Medicine, 3Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, 4Southern Illinois University School of Medicine


AHNS-083

SURGICAL MARGINS IN SALIVARY MALIGNANCY: WHEN IS NEAR ENOUGH, GOOD ENOUGH?

Salivary

M A Hanson, MD, X Mimica, MD, M McGill, BS, J Wu, MD, D K Zanoni, MD, A Hay, MD, J P Shah, MD, R J Wong, MD, M A Cohen, MD, S G Patel, MD, I Ganly, MD, PhD

Memorial Sloan Kettering Cancer Center


AHNS-084

THE ROLE OF ELECTIVE NECK DISSECTION IN CN0 PATIENTS WITH HIGH-GRADE PAROTID CANCER AMONG A HOSPITAL-BASED NATIONAL COHORT, 2004 – 2013.

Salivary

Richard A Harbison, MD, MS1, Alan Gray1, Ted Westling2, Marco Carone1, Neal Futran1, Jeffrey J Houlton1

1University of Washington, 2University of Pennsylvania


AHNS-085

SINGLE CELL RNA-SEQUENCING REVEALS INTER-TUMORAL AND INTRA-TUMORAL HETEROGENEITY IN MYB-DRIVEN PROGRAMS IN ADENOID CYSTIC CARCINOMA

Salivary

Anuraag S Parikh, MD1, Sidharth V Puram, MD, PhD2, Yotam Drier, PhD3, William C Faquin, MD, PhD1, Armida Lefranc-Torres, MD1, Jeremy D Richmon, MD1, Kevin S Emerick, MD1, Daniel G Deschler, MD1, Mark A Varvares, MD1, Bradley E Bernstein, MD, PhD3, Derrick T Lin, MD1

1Massachusetts Eye and Ear Infirmary, 2Massachusetts Eye and Ear Infirmary, Ohio State University, 3Massachusetts General Hospital


AHNS-086

USE OF MACHINE LEARNING TO DEVELOP A CLINICAL PREDICTION MODEL FOR SURVIVAL IN ORAL CANCER

Mucosal - HPV Negative

Omar Karadaghy, MD, Matt Shew, Jacob New, Andres Bur

University of Kansas Medical Center


AHNS-087

TMEM16A IS A POTENTIAL BIOMARKER FOR THE DEVELOPMENT AND MALIGNANT TRANSFORMATION OF SQUAMOUS EPITHELIAL DYSPLASIA

Mucosal - HPV Negative

Hannah L Schwarzbach1, Silvia Cruz-Rangel, PhD2, Aaron Berg, MD3, Umamaheswar Duvvuri, MD, PhD2

1University of Pittsburgh School of Medicine, 2Department of Otolaryngology – Head and Neck Surgery, University of Pittsburgh Medical Center, 3Department of Pathology, University of Pittsburgh Medical Center


AHNS-088

DNA SEQUENCING OF HUMAN CANCER GENES AND HUMAN PAPILLOMAVIRUS GENOMES TO CLASSIFY AND MONITOR HEAD AND NECK SQUAMOUS CARCINOMA

Other

Michelle Tanner, Erin Mamuyac, Eugenie Du, Samip Patel, Jared Weiss, Mark Weissler, Trevor Hackman, Gaorav Gupta, Jose Zevallos, Sandy Elmore, Renee Betancourt, Leigh Thorne, Margaret Gulley

University of North Carolina


AHNS-089

P16 AND HUMAN PAPILLOMAVIRUS IN SINONASAL CARCINOMA

Mucosal - HPV Positive

Erin R Cohen, MD, Caitlin Coviello, BS, Simon Menaker, BS, Ernesto Martinez Duarte, MD, Carmen Gomez, MD, Kaming Lo, MPH, Darcy Kerr, MD, Elizabeth J Franzmann, MD, Jason Leibowitz, MD, Zoukaa B Sargi, MD, MPH

University of Miami Miller School of Medicine


AHNS-090

GROSS TUMOR VOLUME AND INVASIVE TUMOR VOLUME USING 3 TESLA MRI AS PREDICTORS OF CERVICAL LYMPH NODE METASTASIS AND SURVIVAL IN ORAL TONGUE CANCER

Mucosal - HPV Negative

Rachad Mhawej, MD1, Rebecca Cornelius, MD2, Teresa A Smith2, Kattia F Moreno Giraldo, MD2, Yash J Patil, MD, MPH2

1University of Oklahoma Health Sciences Center, 2University of Cincinnati